These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1835269)

  • 1. Effect of etodolac, a new nonsteroidal anti-inflammatory drug, in MRL/lpr mice with articular lesions.
    Yoshida-Suzuka H; Nakamura Y; Shibata Y; Kimura K
    Agents Actions; 1991 Jul; 33(3-4):310-3. PubMed ID: 1835269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ER-34122, a novel dual 5-lipoxygenase/cyclooxygenase inhibitor, on indices of early articular lesion in MRL/MpJ-lpr/lpr mice.
    Horizoe T; Nagakura N; Chiba K; Shirota H; Shinoda M; Numata H; Kobayashi S; Abe C
    Inflamm Res; 1999 Aug; 48(8):432-6. PubMed ID: 10493160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological properties of the new non-steroidal anti-inflammatory agent etodolac.
    Inoue K; Fujisawa H; Sasaki Y; Nishimura T; Nishimura I; Inoue Y; Yokota M; Masuda T; Ueda F; Shibata Y
    Arzneimittelforschung; 1991 Mar; 41(3):228-35. PubMed ID: 1651085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyarthritis in MRL lpr/lpr mice.
    Pataki A; Rordorf-Adam C
    Rheumatol Int; 1985; 5(3):113-20. PubMed ID: 4012184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-inflammatory effect and low ulcerogenic activity of etodolac, a cyclooxygenase-2 selective non-steroidal anti-inflammatory drug, on adjuvant-induced arthritis in rats.
    Tachibana M; Inoue N; Yoshida E; Matsui M; Ukai Y; Yano J
    Pharmacology; 2003 Jun; 68(2):96-104. PubMed ID: 12711837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of etodolac on type-II collagen-induced arthritis in mice.
    Inoue K; Motonaga A; Suzuka H; Yoshifusa H; Fujisawa H; Nishimura T; Inoue Y; Ueda F; Shibata Y; Kimura K
    Agents Actions; 1993 Jul; 39(3-4):187-94. PubMed ID: 8304247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of etodolac on articular and bone pathology associated with adjuvant arthritis in rats: a comparison with aspirin and naproxen.
    Martel RR; Klicius J; Metcalf G
    Agents Actions; 1984 Feb; 14(2):257-64. PubMed ID: 6231845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of the efficacy of etodolac in arthritic disorders.
    Bacon PA
    Eur J Rheumatol Inflamm; 1990; 10(1):22-34. PubMed ID: 2146130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Open clinical study on the efficacy and tolerance of acemetacin in rheumatoid arthritis and osteoarthrosis].
    Gospodinoff A; Fiore L; Dardano B; Fiore D; Scapato P
    Clin Ter; 1989 Jul; 130(2):109-13. PubMed ID: 2529083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etodolac and the treatment of arthritis.
    Scott DL
    Eur J Rheumatol Inflamm; 1990; 10(1):1-2. PubMed ID: 2146128
    [No Abstract]   [Full Text] [Related]  

  • 11. A review of the antiarthritic efficacy and safety of etodolac.
    Zvaifler N
    Clin Rheumatol; 1989 Mar; 8 Suppl 1():43-53. PubMed ID: 2525982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandins in inflammatory bone pathology: mechanism and therapeutic benefit of etodolac.
    Hayward MA; Howard GA; Neuman RG; Wood DD; Weichman BM; Van Sickle DC
    Agents Actions; 1989 Mar; 26(3-4):310-8. PubMed ID: 2525314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of prostaglandin biosynthesis by etodolac. I. Selective activities in arthritis.
    Neuman RG; Wilson BD; Barkley M; Kimball ES; Weichman BM; Wood DD
    Agents Actions; 1987 Jun; 21(1-2):160-6. PubMed ID: 2957897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of anti-inflammatory action of etodolac.
    Inoue K; Motonaga A; Nishimura T; Yokota M; Miki N; Fujisawa H; Ueda F; Shibata Y; Kimura K
    Arzneimittelforschung; 1991 Mar; 41(3):235-9. PubMed ID: 1714278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind, parallel comparison of etodolac and indomethacin in patients with osteoarthritis of the knee.
    Karbowski A
    Curr Med Res Opin; 1991; 12(5):309-17. PubMed ID: 1825972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of 4,6-diethyl-1,3,4,5-tetrahydropyrano[4,3-b]indole-4-acetic acid, an isomer of etodolac.
    Hughes P; DeVirgilio J; Humber LG; Chau T; Weichman B; Neuman G
    J Med Chem; 1989 Sep; 32(9):2134-7. PubMed ID: 2527995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of extracellular matrix metabolism in rabbit articular chondrocytes and human rheumatoid synovial cells by the non-steroidal anti-inflammatory drug etodolac. I: Collagen synthesis.
    Mauviel A; Redini F; Loyau G; Pujol JP
    Agents Actions; 1990 Nov; 31(3-4):345-52. PubMed ID: 2150740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of etodolac in subjects with renal impairment.
    Brater DC
    Eur J Rheumatol Inflamm; 1990; 10(1):44-55. PubMed ID: 2146131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etodolac: the role of a new NSAID in the management of arthritis and pain. Tenth Pan American Congress of Rheumatology and the Seventeenth Congress of the Mexican Society of Rheumatology. Guadalajara, Mexico, March 15, 1990.
    Rheumatol Int; 1990; 10 Suppl():1-34. PubMed ID: 1982022
    [No Abstract]   [Full Text] [Related]  

  • 20. Etodolac: efficacy in osteoarthritis and effects on chondrocyte function.
    Bacon PA
    Rheumatol Int; 1990; 10 Suppl():3-7. PubMed ID: 2150570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.